-activated K ϩ (SK) channels play an important role in regulating the frequency and in shaping urinary bladder smooth muscle (UBSM) action potentials, thereby modulating contractility. Here we investigated a role for the SK2 member of the SK family (SK1-3) utilizing: 1) mice expressing -galactosidase (-gal) under the direction of the SK2 promoter (SK2 -gal mice) to localize SK2 expression and 2) mice lacking SK2 gene expression (SK2 Ϫ/Ϫ mice) to assess SK2 function. In SK2 -gal mice, UBSM staining was observed, but staining was undetected in the urothelium. Consistent with this, urothelial SK2 mRNA was determined to be 4% of that in UBSM. Spontaneous phasic contractions in wild-type (SK2 ϩ/ϩ ) UBSM strips were potentiated (259% of control) by the selective SK channel blocker apamin (EC 50 ϭ 0.16 nM), whereas phasic contractions of SK2 Ϫ/Ϫ strips were unaffected. Nerve-mediated contractions of SK2 ϩ/ϩ UBSM strips were also increased by apamin, an effect absent in SK2 Ϫ/Ϫ strips. Apamin increased the sensitivity of SK2 ϩ/ϩ UBSM strips to electrical field stimulation, since pretreatment with apamin decreased the frequency required to reach a 50% maximal contraction (vehicle, 21 Ϯ 4 Hz, n ϭ 6; apamin, 12 Ϯ 2 Hz, n ϭ 7; P Ͻ 0.05). In contrast, the sensitivity of SK2 Ϫ/Ϫ UBSM strips was unaffected by apamin. Here we provide novel insight into the molecular basis of SK channels in the urinary bladder, demonstrating that the SK2 gene is expressed in the bladder and that it is essential for the ability of SK channels to regulate UBSM contractility.bladder; contractility; small-conductance calcium-activated potassium channel; apamin THE COORDINATION OF NEURONAL and smooth muscle electrical activity is critical to the maintenance of proper urinary bladder function. Micturition occurs through the initiation of action potentials within the parasympathetic nerves leading to the bladder. These neuronal action potentials on reaching efferent terminals evoke the release of the excitatory neurotransmitters, acetylcholine and ATP. Acetylcholine and ATP bind to muscarinic (M 2 , M 3 ) and purinergic (P 2X1 ) receptors, respectively, located in the urinary bladder smooth muscle (UBSM) membrane. These transmitters contract the bladder via a coordinated potentiation of UBSM action potentials, which occur "spontaneously" during bladder filling functioning to maintain an appropriate basal bladder tone (10).Overactive bladder, a major underlying cause of urinary incontinence, is frequently caused by alterations in neuronal and/or UBSM electrical activity. Currently, the main therapy used to treat overactive bladder is muscarinic receptor antagonists that function to reduce the coupling of excitatory acetylcholine to UBSM muscarinic receptors. These agents are somewhat effective but have significant side effects, such as dry mouth, and in some cases can lead to incomplete urine voiding during micturition. Therefore, the identification of novel targets to be used for the development of better therapies for overactive bladder and urinar...